Boehringer Ingelheim and Highmark Inc: A Value-Driven Partnership Focused on Outcomes in Diabetes and Cardiovascular Disease

This Profiles in Care stakeholder case study highlights the development and management of an innovative value-based partnership between Boehringer Ingelheim and Highmark Inc, which focuses on outcomes in diabetes and cardiovascular disease, including the rationale for participation in the partnership, areas of focus, expected benefits, and organizational challenges and solutions.

Download PDF: Boehringer Ingelheim and Highmark Inc: A Value-Driven Partnership Focused on Outcomes in Diabetes and Cardiovascular Disease

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Boehringer Ingelheim and Highmark Inc: A Value-Driven Partnership Focused on Outcomes in Diabetes and Cardiovascular Disease

Related Content

Why CGM Access and Diabetes Amputations Are Part of the Same Systemic Problem: Alyson K. Myers, MD

Culturally Tailored Diabetes Care Can Improve Outcomes and Reduce Costs: Alyson K. Myers, MD

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

Trending on AJMC

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD

First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD

AI Reshaping Diabetes Care From Nutrition to Clinical Decisions

COVID Postexposure Prophylaxis Expands Prevention Toolkit: Noah Greenspan, DPT, PT